Jean-Bernard Auliac

7PUBLICATIONS
12CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 24, 2026
Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study.

|Jun 05, 2024
Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.

Mateo Sanchis-Borja, Florian Guisier, Aurélie Swalduz

|Mar 08, 2024
Resected EGFR-mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study).

Jean-Bernard Auliac, Pascal-Alexandre Thomas, Olivier Bylicki

|May 05, 2021
Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis.

Isabelle Monnet, Alain Vergnenègre, Gilles Robinet

|Jan 07, 2021
Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small-Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study).

Jean-Bernard Auliac, Florian Guisier, Acya Bizieux

|Dec 05, 2020
Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019.

Jean-Bernard Auliac, Sophie Bayle, Pascal Do

Pageof 2

Frequent Collaborators

6 joint publications

Christos Chouaïd

5 joint publications

Florian Guisier

2 joint publications

Olivier Bylicki

1 joint publications

Alain Vergnenègre